BriaCell Therapeutics Corp.

BCTX ·Healthcare, Drug Manufacturers - General, British Columbia, Canada
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-K Oct 28, 2026 10-K
8-K Jun 26, 2026 8-K
10-Q Jun 9, 2026 10-Q
8-K Jun 3, 2026 8-K
424B5 Jun 2, 2026 424B5
8-K Mar 31, 2026 8-K
10-Q Mar 10, 2026 10-Q
8-K Mar 9, 2026 8-K
25-NSE Feb 26, 2026
8-K Feb 20, 2026 8-K
DEF 14A Feb 12, 2026 DEF 14A
SCHEDULE 13G Jan 23, 2026
8-K Jan 15, 2026 8-K
424B4 Jan 14, 2026 424B4
EFFECT Jan 13, 2026
S-1MEF Jan 13, 2026 S-1MEF
CERT Jan 13, 2026
8-A12B Jan 13, 2026 8-A12B
CORRESP Jan 8, 2026
CORRESP Jan 8, 2026
CORRESP Jan 6, 2026
CORRESP Jan 6, 2026
8-K Dec 29, 2025 8-K
FWP Dec 23, 2025 FWP
S-1 Dec 23, 2025 S-1
← Newer Page 1 of 13 · 324 filings Older →